[Federal Register Volume 68, Number 166 (Wednesday, August 27, 2003)]
[Notices]
[Page 51582]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-21855]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Child Health and Human Development; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel, Concept Review--``The Synthesis 
and Testing of Norsteroidal and Nonhormonal Male Contraceptive 
Agents.''
    Date: September 17, 2003.
    Time: 12 p.m. to 2 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6100 Executive Boulevard, 
Rockville, MD 20852, (Telephone Conference Call).
    Contract Person: Hameed Khan, PhD, Scientific Review 
Administrator, Division of Scientific Review, National Institute of 
Child Health and Human Development, National Institutes of Health, 
6100 Executive Boulevard, Room 5E01, Bethesda, MD 20892, (301) 435-
6902, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: August 20, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-21855 Filed 8-26-03; 8:45 am]
BILLING CODE 4140-01-M